Medicine
Potassium chloride 1500 mg extended-release tablet
Potassium chloride 1500 mg extended-release tablet is a generic prescription medicine for oral use, made by 23 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature 20° - 25°C (68° - 77°F), excursions permitted to 15°…
Key facts
- Active ingredient (INN)
- Potassium chloride
- Brand
- Sold under the generic name
- Strength
- 1500 mg
- Dosage form
- Extended-release tablet
- Route
- Oral
- Packs
- 100 tablets, 500 tablets, 1000 tablets and 128 more
- Manufacturers
- Zydus LifesciencesIndiaAurobindo PharmaIndiaGranules IndiaIndiaCamber PharmaceuticalsIndiaA-S Medication SolutionsAdvagen PharmaUpsher-SmithLaboratoriesSlate Run PharmaceuticalsUpsher-Smith LaboratoriesXLCare Pharmaceuticals23 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Store at room temperature 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA01 Potassium chloride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 20 November 1998
- Identifiers
- RxCUI 198116, 628953, 2693253 +3DailyMed set ID 8000e242-fe20-4d02-8f7d-97298857cf4c, ace1eb11-b925-405a-b772-58c60b3ca7d4, 099c3a36-f460-4191-80e5-0c4153a5c713 +37NDC 72888-076, 70518-4383, 70771-1600 +37Application ANDA215725, ANDA214452, ANDA210395 +8
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 23 labelers. The register lists 131 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 tablet, extended release in 1 bottle | 68382-740-01 | Zydus LifesciencesIndia | 3 February 2022 |
| 500 tablet, extended release in 1 bottle | 68382-740-05 | Zydus LifesciencesIndia | 3 February 2022 |
| 1000 tablet, extended release in 1 bottle | 68382-740-10 | Zydus LifesciencesIndia | 3 February 2022 |
| 1000 tablet, extended release in 1 bottle | 70771-1600-0 | Zydus LifesciencesIndia | 3 February 2022 |
| 100 tablet, extended release in 1 bottle | 70771-1600-1 | Zydus LifesciencesIndia | 3 February 2022 |
| 500 tablet, extended release in 1 bottle | 70771-1600-5 | Zydus LifesciencesIndia | 3 February 2022 |
| 100 tablet, extended release in 1 bottle | 59651-431-01 | Aurobindo PharmaIndia | 31 March 2021 |
| 500 tablet, extended release in 1 bottle | 59651-431-05 | Aurobindo PharmaIndia | 31 March 2021 |
| 90 tablet, extended release in 1 bottle | 59651-431-90 | Aurobindo PharmaIndia | 31 March 2021 |
| 100 tablet, extended release in 1 bottle | 31722-135-01 | Camber PharmaceuticalsIndia | 20 January 2021 |
| 500 tablet, extended release in 1 bottle | 31722-135-05 | Camber PharmaceuticalsIndia | 20 January 2021 |
| 100 tablet, extended release in 1 bottle | 70010-135-01 | Granules IndiaIndia | 30 January 2021 |
| 500 tablet, extended release in 1 bottle | 70010-135-05 | Granules IndiaIndia | 30 January 2021 |
| 1000 tablet, extended release in 1 bottle | 70010-135-10 | Granules IndiaIndia | 30 January 2021 |
| 100 tablet, film coated, extended release in 1 bottle | 72888-076-01 | Advagen Pharma | 25 July 2022 |
| 500 tablet, film coated, extended release in 1 bottle | 72888-076-05 | Advagen Pharma | 25 July 2022 |
| 1000 tablet, extended release in 1 bottle | 72888-099-00 | Advagen Pharma | 16 June 2023 |
| 100 tablet, extended release in 1 bottle | 72888-099-01 | Advagen Pharma | 16 June 2023 |
| 100 tablet, film coated, extended release in 1 bottle | 70436-153-01 | Slate Run Pharmaceuticals | 1 February 2020 |
| 500 tablet, film coated, extended release in 1 bottle | 70436-153-02 | Slate Run Pharmaceuticals | 1 February 2020 |
| 100 tablet, extended release in 1 bottle, plastic | 24979-232-01 | Upsher-Smith Laboratories | 10 April 2023 |
| 500 tablet, extended release in 1 bottle, plastic | 24979-232-02 | Upsher-Smith Laboratories | 10 April 2023 |
| 1000 tablet, extended release in 1 bottle | 0832-5325-10 | Upsher-SmithLaboratories | 21 June 2019 |
| 100 tablet, extended release in 1 bottle | 0832-5325-11 | Upsher-SmithLaboratories | 21 June 2019 |
| 500 tablet, extended release in 1 bottle | 0832-5325-15 | Upsher-SmithLaboratories | 21 June 2019 |
| 100 tablet, extended release in 1 bottle | 72865-196-01 | XLCare Pharmaceuticals | 4 March 2021 |
| 500 tablet, extended release in 1 bottle | 72865-196-05 | XLCare Pharmaceuticals | 4 March 2021 |
| 30 tablet, extended release in 1 bottle | 50090-3700-0 | A-S Medication Solutions | 19 October 2018 |
| 60 tablet, extended release in 1 bottle, plastic | 50090-3700-1 | A-S Medication Solutions | 26 July 2016 |
| 90 tablet, extended release in 1 bottle, plastic | 50090-3700-2 | A-S Medication Solutions | 26 July 2016 |
| 30 tablet, extended release in 1 bottle | 50090-5665-0 | A-S Medication Solutions | 15 September 2021 |
| 60 tablet, extended release in 1 bottle | 50090-5665-1 | A-S Medication Solutions | 15 September 2021 |
| 90 tablet, extended release in 1 bottle | 50090-5665-2 | A-S Medication Solutions | 15 September 2021 |
| 30 tablet, extended release in 1 bottle | 50090-6253-0 | A-S Medication Solutions | 2 December 2022 |
| 60 tablet, extended release in 1 bottle | 50090-6253-1 | A-S Medication Solutions | 2 December 2022 |
| 90 tablet, extended release in 1 bottle | 50090-6253-2 | A-S Medication Solutions | 2 December 2022 |
| 30 tablet, extended release in 1 bottle | 50090-6866-0 | A-S Medication Solutions | 4 December 2023 |
| 60 tablet, extended release in 1 bottle | 50090-6866-1 | A-S Medication Solutions | 4 December 2023 |
| 90 tablet, extended release in 1 bottle | 50090-6866-2 | A-S Medication Solutions | 4 December 2023 |
| 90 tablet, extended release in 1 bottle | 50090-6867-0 | A-S Medication Solutions | 4 December 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Potassium chloride 1500 mg extended-release tablet.
Other strengths and forms of Potassium chloride
Clinical summary
Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KLOR-CON prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Potassium chloride 1500 mg extended-release tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.